A lecturer at the University of Ghana Dr Augustine Ocloo has raised concerns over the actions of the Food and Drugs Authority (FDA) towards COA FS immune booster.
Dr. Ocloo who has researched into COA FS speaking to Francis Abban on the Morning Starr said, it is surprising that the FDA is now making claims against the drug when it has been around since 2016.
According to the researcher, the FDA has more questions to answer over its decision to recall the drug from the market.
“FDA itself hasn’t come out to say the medicine is not good anymore, it is some batches they have issues with and that can be resolved. Since 2016, this product has been around since so does it mean that since 2016 the FDA hasn’t analysed it from microbiology? so why all of a sudden the whole product has become bad. I’m not saying they are cooking up stories but these are questions we should ask them,” he said.
Many Ghanaians have expressed surprise over the FDA’s action considering the fact that COA FS was on high demand following the outbreak of the covid-19 pandemic. Before the FDA’s ban on the wonder drug, there were hints that some respected officials were denigrating the efficacy of the drug, which have been acclaimed by many Ghanaians and some foreigners, who have tried and tested it.
Meanwhile, Producers of immune booster drug COA FS, Centre of Awareness Global Peace Mission, have rejected claims by the Food and Drugs Authority (FDA) that the product is unwholesome for human consumption.
According to the manufacturers, a new laboratory test at the Cape Coast Teaching Hospital has proven that claims by the FDA about the drug are inaccurate.
In a statement, the manufacturers said: “We, therefore, find the Press Statement from the FDA that they detected a microbial contamination in COA FS as a surprise. The self-preserving nature of COA FS is the reason why we have never received any of the adverse drug reactions enumerated in the FDA Statement over the period. Contrary to the claims in the Press Statement, the evidence rather indicates that people with weakened immune systems and or kidney malfunctions, rather got better after taking COA FS. We find it unfortunate that the FDA seeks to associate the alleged contamination in COA FS to kidney failure. A thorough search through scientific literature shows that it is a particular strain of E. Coli that causes kidney problem, but the FDA has not provided any data to prove that this particular strain has been found in COA FS”.
